2-hydroxy-6-methylpurine has been researched along with Hyperuricemia in 1 studies
*Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, CE; Hille, R; Pauff, JM; Zhang, J | 1 |
1 other study(ies) available for 2-hydroxy-6-methylpurine and Hyperuricemia
| Article | Year |
|---|---|
Substrate orientation in xanthine oxidase: crystal structure of enzyme in reaction with 2-hydroxy-6-methylpurine.
Topics: Animals; Binding Sites; Catalysis; Cattle; Crystallography, X-Ray; Humans; Hyperuricemia; Molybdenum; NAD; Protein Binding; Protein Structure, Tertiary; Purines; Xanthine Oxidase | 2008 |